Publisher Correction: EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma

Sci Rep. 2018 Jan 18;8(1):1456. doi: 10.1038/s41598-018-19645-y.

Chi-Chen Fan^{1

2}, Wei-Chung Cheng^{3

4}, Yu-Chuen Huang^{5

6}, Yuh-Pyng Sher^{4

7}, Nia-Jhen Liou⁷, Yu-Chuan Chien⁴, Pei-Shan Lin⁷, Pei-Syuan Lin⁷, Chung-Hsuan Chen^{8

9

10

11}, Wei-Chao Chang¹²

¹ Department of Superintendent Office, Mackay Memorial Hospital, Taipei, Taiwan.
² Department of Medical Laboratory Science and Biotechnology, Yuanpei University, Hsinchu, Taiwan.
³ Research Center for Tumor Medical Science, China Medical University, Taichung, Taiwan.
⁴ Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
⁵ School of Chinese Medicine, China Medical University, Taichung, Taiwan.
⁶ Genetics Center, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
⁷ Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan.
⁸ Genomics Research Center, Academia Sinica, Taipei, Taiwan.
⁹ Institute of Biochemistry & Molecular Biology, National Yang-Ming University, Taipei, Taiwan.
¹⁰ Department of Chemistry, National Taiwan University, Taipei, Taiwan.
¹¹ Institute of Atomic & Molecular Sciences, Academia Sinica, Taipei, Taiwan.
¹² Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan. T21443@mail.cmuh.org.tw.

Abstract

A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.